A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

A large case-control study suggests that calcium channel blockers are the only antihypertensives that reduce the risk for Parkinson disease ... of antihypertensive drugs: angiotensin-converting ...

And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat — those of the brain, like Parkinson’s. But now, at least for Parkinson’s ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers. For their research, published in ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was associated with reduced incidence of Parkinson’s disease, data show.

Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds By India Edwards HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could ...

Doctors may prescribe these drugs to treat Parkinson’s disease or disorders that cause unwanted movement, such as restless legs syndrome. Genes may be involved in certain conditions that ...